Univo IRB
Ashton Poole is an accomplished executive with extensive experience in finance and corporate governance. Currently serving as a Board Member for Univo IRB and InformedDNA since January 2024, Ashton has also been a Partner at QHP Capital since March 2021. Previous roles include Board Member positions at CoreRx, Inc. and Azurity Pharmaceuticals, and Partner, Private Equity at NovaQuest Capital Management. Ashton held the positions of Chairman and Chief Executive Officer at Triangle Capital Corporation from July 2013 to August 2018, focusing on corporate strategy, investment origination, and investor relations. Prior to that, Ashton was a Managing Director in the Investment Banking Division at Morgan Stanley, specializing in corporate finance and M&A services for Fortune 500 companies. Ashton began the career as a Senior Analyst at Gemini Consulting. Educational qualifications include an MBA from Northwestern University’s Kellogg Graduate School of Management and a BS in Business Administration from the University of North Carolina at Chapel Hill.
This person is not in any teams
Univo IRB
Led by a team with 60+ years of IRB experience, UnivoTM IRB is your trusted partner. Combining solution-oriented agility and forward thinking technology with a commitment to customer service, we help you navigate the path to IRB approval, faster. Rely on Univo IRB to confidently guide your study forward while protecting patients every step of the way.